Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-22 Sale | 2024-04-24 4:17 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $3.0979 | $15,490 | 390,092 (Indirect Direct) | View |
| 2024-03-06 Sale | 2024-03-08 6:29 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $5.0394 | $269,682 | 474,290 (Direct) | View |
| 2024-02-16 Sale | 2024-02-21 4:10 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $4.8624 | $2,358 | 336,319 (Direct) | View |
| 2024-02-05 Sale | 2024-02-07 5:21 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 1,200 | $4.1409 | $4,969 | 303,580 (Direct) | View |
| 2024-02-05 Sale | 2024-02-07 5:21 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 3,819 | $4.1428 | $15,821 | 114,149 (Direct) | View |
| 2023-03-21 Sale | 2023-03-23 7:31 pm | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 144,911 | $3.7256 | $539,879 | 778,997 (Direct) | View |
| 2022-08-09 Sale | 2022-08-11 4:55 pm | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 550,000 | $13.03 | $7,166,610 | 12,530,909 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-18 5:48 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 121,975 | $0 | 1,575,254 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 7:38 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 95,000 | $0 | 398,580 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 7:36 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 170,000 | $0 | 541,092 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 7:35 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 170,000 | $0 | 284,149 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 7:34 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 170,000 | $0 | 706,544 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 6:29 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $0 | 474,290 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 6:29 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $1.03 | 474,290 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:10 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $0 | 336,319 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $1.03 | 336,319 (Direct) | View |
| 2023-12-04 Option Award | 2023-12-06 4:07 pm | N/A 2033-12-04 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 2,026,970 | $0 | 2,026,970 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 4:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 16,611 | $1.49 | 304,780 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 4:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Financial Officer | 20,763 | $1.49 | 253,533 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:23 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:22 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:21 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:20 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:20 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:19 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:18 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 4:33 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 120,846 | $0 | 321,391 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 4:32 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Financial Officer | 151,058 | $0 | 274,296 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 7:56 pm | N/A 2033-04-12 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 131,250 | $0 | 131,250 (Direct) | View |
Ownership | 2023-04-14 7:55 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 0 | $0 | 570,660 (Indirect) | View |
| 2023-04-11 Option Award | 2023-04-13 5:29 pm | N/A 2033-04-11 | Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer | 318,750 | $0 | 318,750 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:27 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 7,452 | $0 | 256,535 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:27 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 7,452 | $1.03 | 256,535 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 7:31 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 350,244 | $0 | 778,997 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 7:31 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 350,244 | $1.03 | 778,997 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:52 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Flores Osvaldo Chief Executive Officer | 1,275,000 | $0 | 1,275,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:52 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations | 97,500 | $0 | 290,545 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:51 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:50 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 284,375 | $0 | 306,250 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:49 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 284,375 | $0 | 380,468 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:49 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer | 284,375 | $0 | 385,738 (Direct) | View |
| 2022-10-01 Option Award | 2022-10-03 4:08 pm | N/A 2032-10-01 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2022-10-01 Option Award | 2022-10-03 4:07 pm | N/A 2032-10-01 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2022-08-09 Other | 2022-08-11 4:55 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 364,800 | $0 | 12,530,909 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 19,872 | $0 | 19,872 (Direct) | View |